This effects of BMAL1 on Ang II-induced CH, on the one hand, suggested that people or animals with dysrhythmia are more likely to suffer from CH, on the other hand, BMAL1 might be used as an ideal target of new drugs for the prevention and treatment of patients with CH. The gene discussed is AGT; the disease is cyclic hematopoiesis.